Related Experiment Video
Updated: Jun 11, 2026

Biosensor for Detection of Antibiotic Resistant Staphylococcus Bacteria
Published on: May 8, 2013
Linezolid-resistant Staphylococcus aureus isolated from 2006 through 2008 at six hospitals in Japan
Yurika Ikeda-Dantsuji1, Hideaki Hanaki, Fuminori Sakai
1Research Center for Anti-Infectious Drugs, Kitasato Institute for Life Sciences, Kitasato University, Tokyo, Japan.
Abstract:
Limited use of linezolid for treating methicillin-resistant Staphylococcus aureus (MRSA) infection was approved in Japan in 2006. We report here the status of linezolid-resistant MRSAs in Japan. Eleven linezolid-resistant clinical isolates from 11 patients at six hospitals were collected from 2006 through 2008. The minimal inhibitory concentration (MIC) of linezolid in these strains varied from 8 to 64 μg/ml. All strains had at least one G2576T mutation in the chromosomal gene(s) encoding domain V of the 23S ribosomal RNA (rRNA). Chromosomal DNA encoding five copies of the domain V region was analyzed by polymerase chain reaction (PCR). Strains with the linezolid MICs of 64, 32, 16, and 8 μg/ml had the G2576T mutation(s) in four, three (or four), two, and one copy of the 23S rRNA genes, respectively. These results suggest that the level of linezolid resistance seems to be roughly correlated with the number of mutations in the genes encoding 23S rRNA. DNA samples from all 11 strains were subjected to pulsed-field gel electrophoresis and were classified into seven independent clones having >92% identity. Among the 11 patients, five had been treated with linezolid and the remainder, in two hospitals, had no history of prior linezolid use. The results suggested possible nosocomial infections by linezolid-resistant MRSA.
Insights
Linezolid resistance in methicillin-resistant Staphylococcus aureus (MRSA) emerged in Japan. Mutations in 23S ribosomal RNA genes correlated with resistance levels, suggesting potential nosocomial spread.
Area of Science:
- Microbiology
- Infectious Diseases
- Genetics
Background:
- Linezolid is an important antibiotic for treating infections caused by Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA).
- Limited use of linezolid for MRSA infections was approved in Japan in 2006.
- Monitoring the emergence of antibiotic resistance is crucial for effective treatment strategies.
Purpose of the Study:
- To investigate the status and genetic basis of linezolid-resistant MRSA in Japan.
- To determine the correlation between specific mutations and the level of linezolid resistance.
- To assess the clonal diversity and potential transmission routes of linezolid-resistant MRSA.
Main Methods:
- Collection and characterization of 11 linezolid-resistant MRSA clinical isolates from Japanese hospitals (2006-2008).
- Determination of minimal inhibitory concentrations (MICs) for linezolid.
- Analysis of mutations in the 23S ribosomal RNA (rRNA) genes using polymerase chain reaction (PCR).
- Pulsed-field gel electrophoresis (PFGE) for clonal typing.
Main Results:
- All 11 strains exhibited linezolid resistance with MICs ranging from 8 to 64 μg/ml.
- A G2576T mutation in the 23S rRNA genes was present in all resistant strains.
- The level of linezolid resistance correlated with the number of mutated 23S rRNA gene copies.
- Seven distinct clones were identified among the 11 isolates, indicating potential transmission.
- Some resistant strains were found in patients with no prior linezolid exposure, suggesting possible nosocomial spread.
Conclusions:
- The emergence of linezolid-resistant MRSA in Japan is confirmed.
- The G2576T mutation in 23S rRNA genes is a key mechanism conferring linezolid resistance.
- The number of mutated rRNA genes influences the degree of resistance.
- Linezolid-resistant MRSA may spread within healthcare settings, necessitating vigilant surveillance and infection control measures.
Related Concept Videos
Clinical Significance of Antibiotic Resistance
Mechanism of Antibiotic Resistance in MRSA
Staphylococcal Skin Infections
Development of Antibiotic Resistance
Antimicrobial Effectiveness
Antibiotic Selection